Log in

NYSE:CHEChemed Stock Price, Forecast & News

$473.47
-1.50 (-0.32 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$468.97
Now: $473.47
$477.12
50-Day Range
$427.89
MA: $460.09
$482.27
52-Week Range
$330.01
Now: $473.47
$513.75
Volume79,900 shs
Average Volume127,428 shs
Market Capitalization$7.51 billion
P/E Ratio33.87
Dividend Yield0.27%
Beta0.7
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$17.19 per share
Book Value$45.39 per share

Profitability

Net Income$219.92 million

Miscellaneous

Employees16,641
Market Cap$7.51 billion
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock been impacted by COVID-19 (Coronavirus)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHE shares have increased by 14.4% and is now trading at $473.47. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Chemed.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Chemed.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Tuesday, April, 28th. The company reported $3.68 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.65 by $0.03. The firm earned $515.80 million during the quarter, compared to analyst estimates of $523.04 million. Chemed had a net margin of 11.60% and a return on equity of 35.99%. Chemed's revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the business earned $2.92 EPS. View Chemed's earnings history.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Tuesday, May 19th. Shareholders of record on Thursday, May 28th will be paid a dividend of $0.32 per share on Wednesday, June 17th. This represents a $1.28 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date is Wednesday, May 27th. View Chemed's dividend history.

What price target have analysts set for CHE?

4 Wall Street analysts have issued 12 month price objectives for Chemed's shares. Their forecasts range from $490.00 to $535.00. On average, they anticipate Chemed's share price to reach $515.00 in the next year. This suggests a possible upside of 8.8% from the stock's current price. View analysts' price targets for Chemed.

Has Chemed been receiving favorable news coverage?

Press coverage about CHE stock has trended neutral on Sunday, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Chemed earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Chemed.

Are investors shorting Chemed?

Chemed saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 197,500 shares, a decline of 25.4% from the June 15th total of 264,900 shares. Based on an average daily trading volume, of 119,000 shares, the short-interest ratio is presently 1.7 days. Approximately 1.3% of the company's shares are short sold. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Altria Group (MO), Target (TGT), Verizon Communications (VZ), AbbVie (ABBV), Boeing (BA), CVS Health (CVS), Chevron (CVX) and Johnson & Johnson (JNJ).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.12%), Envestnet Asset Management Inc. (0.30%), Contravisory Investment Management Inc. (0.07%), Hexavest Inc. (0.01%) and 6 Meridian (0.00%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View institutional ownership trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, and 6 Meridian. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, Spencer S Lee, and Walter L Krebs. View insider buying and selling activity for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Contravisory Investment Management Inc., Envestnet Asset Management Inc., and Hexavest Inc.. View insider buying and selling activity for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $473.47.

How big of a company is Chemed?

Chemed has a market capitalization of $7.51 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.